Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITLECITINIB vs RIVAROXABAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITLECITINIB vs RIVAROXABAN: Safety Overview

Metric RITLECITINIB RIVAROXABAN
Total FAERS Reports 1,441 131,274
Deaths Reported 1 19,233
Death Rate 0.1% 14.7%
Hospitalizations 47 70,513
Average Patient Age 34.7 yrs 70.0 yrs
% Female Patients 65.0% 47.7%
FDA Approval Date Jun 23, 2023 Apr 10, 2025
Manufacturer U.S. Pharmaceuticals Macleods Pharmaceuticals Limited
Route ORAL ORAL
Marketing Status Prescription Prescription